Form 4: Mirum Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Peter Radovich, President and COO of Mirum Pharmaceuticals, sold 1,379 shares of common stock on January 9, 2023, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On January 9, 2023, Peter Radovich, the President and COO of Mirum Pharmaceuticals, sold 1,379 shares of the company's common stock.
- The sale was executed at a price of $20.6223 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Radovich directly owns 33,316 shares of Mirum Pharmaceuticals.
Sentiment
Score: 6
Explanation: Neutral sentiment as the transaction is a routine sale of shares to cover tax obligations, with no indication of a change in the executive's overall confidence in the company.
Industry Context
Executive stock sales are a common occurrence, often related to compensation and tax planning. The sale itself doesn't necessarily indicate a negative outlook on the company's future, especially when it's explicitly stated to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 01/09/2023 | Date of the stock sale transaction. |
| 03/18/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.